The Centers for Medicare and Medicaid Services has opened applications for the Medicare GLP-1 Bridge program, a temporary demonstration offering Medicare Part D beneficiaries access to weight-loss drugs at $50 per month starting July 2026. [1] Applications from Part D plan sponsors are due April 20 — six days from today. The program bridges the gap before CMS's larger BALANCE Model launches. [2]
The bridge exists because of a pricing breakthrough that received remarkably little attention. CMS mass-negotiated GLP-1 pricing with manufacturers at approximately $245 per month net — a fraction of the list prices that have kept Wegovy and Zepbound out of reach for most Medicare beneficiaries. [3] The $50 patient copayment is subsidized by plan sponsors and the federal government.
An estimated 3.4 million Medicare beneficiaries meet the clinical criteria: a body mass index of 30 or greater, or 27 or greater with at least one weight-related comorbidity. [2] The criteria exclude cosmetic weight loss — the bridge is structured as a medical intervention.
CMS is using its innovation authority to test whether covering GLP-1 drugs for weight loss reduces total Medicare spending by preventing downstream costs of obesity-related disease. [1] The hypothesis is straightforward: a $245-per-month drug that prevents a $150,000 bariatric surgery is a net savings.
The contingency is plan participation. The bridge functions only if enough Part D sponsors apply by April 20 and accept CMS's pricing terms. KFF estimates 80 percent of Part D enrollees need to be in participating plans for the program to achieve its goals. [2] If major sponsors decline, the bridge launches with significant gaps.
Medicaid is moving on a parallel track. Several states will begin covering GLP-1 drugs for weight loss under Medicaid in May, ahead of the Medicare launch. [1] The opt-in structure means coverage will vary by state.
On X, physicians who treat obesity and cardiovascular disease are cautiously optimistic — relief that Medicare is finally covering the drugs, concern that the temporary, plan-dependent design could leave the most vulnerable uncovered. [3]
The April 20 deadline will determine whether the bridge is a real program or a policy announcement.
-- NORA WHITFIELD, Chicago